At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting, held from December 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) is set to unveil more than 40 innovations, highlighting its commitment to advancing precision care through AI-enabled technologies and cutting-edge solutions. These innovations are designed to optimize patient outcomes and streamline operational efficiencies, reinforcing GE HealthCare’s position as a leader in medical technology and digital healthcare.
Addressing Challenges in Radiology
GE HealthCare’s advancements are a response to growing pressures in radiology. According to a 2024 report by the American Society of Radiologic Technologists, over half of surveyed radiology professionals reported emotional exhaustion, and 57% felt underappreciated in their roles. Peter Arduini, CEO of GE HealthCare, emphasized the company’s mission to support radiologists by delivering transformative technologies that enhance workflows and decision-making. “Our focus is on creating solutions that enable a more personal and precise approach to care, addressing key challenges from diagnosis to treatment and recovery,” Arduini stated.
Workflow Efficiency Through AI and Digital Solutions
Key innovations showcased at RSNA 2024 include AI-powered tools that improve workflow efficiency and clinical outcomes. Highlights include:
- Clarify DL: This AI-driven bone image reconstruction algorithm enhances diagnostic confidence in bone SPECT imaging.
- nCommand Lite by IONIC Health: A remote collaboration tool supporting magnetic resonance (MR), computed tomography (CT), and PET/CT scanning, enabling radiology staff to focus on patient care.
- True PACS and v7 PACS solutions: These systems integrate Blackford’s AI orchestration platform, streamlining AI-based imaging applications for mammography, lung scans, and more.
- MR Max 3™: A wireless syringeless injector for gadolinium-based contrast media that reduces plastic waste and enhances efficiency.
- Caption Guidance™ and Venue Sprint™: AI-driven ultrasound solutions that guide probe adjustments and provide high-quality imaging at the point of care.
- Vscan Air SL: A handheld ultrasound system with AI capabilities to calculate left ventricular ejection fractions and securely store images in the cloud.
Advancing Personalized and Precise Care
GE HealthCare’s oncology-focused innovations address the need for tailored treatment plans. Integrating AI and digital tools, these solutions aim to enhance diagnoses, increase efficiency, and improve patient outcomes. Key technologies include:
- Aurora: A dual-head SPECT/CT system incorporating deep learning for improved operational and diagnostic capabilities.
- CareIntellect for Oncology: A cloud-based application using generative AI to consolidate and analyze patient data, aiding clinicians in identifying disease progression and treatment deviations.
- Theranostics Solutions: Combining molecular imaging with PET and SPECT systems, these innovations provide precise diagnostic and therapeutic capabilities for conditions like cancer.
Strategic collaborations, such as the partnership with RadNet’s DeepHealth, further GE HealthCare’s goal to redefine radiology workflows through SmartTechnology™ solutions.
Expanding Theranostics and Radiopharmaceutical Applications
Theranostics—a blend of diagnostics and therapeutics—continues to be a focus for GE HealthCare. Recent innovations include:
- MINItrace Magni: A compact cyclotron enabling in-house PET tracer production for broader access to theranostics.
- Omni Legend with Precision DL: An advanced PET/CT scanner offering improved image quality and support for emerging tracers in oncology, neurology, and cardiology.
- Flyrcado™ Injection: The first FDA-approved PET myocardial perfusion imaging agent, providing higher diagnostic accuracy for coronary artery disease.
- MIM Software: A Monte Carlo dosimetry solution for efficient and automated absorbed dose calculations, simplifying traditionally complex processes.
Additional Cutting-Edge Innovations
Beyond oncology and radiology, GE HealthCare is introducing solutions like the Versana Premier, a cost-effective ultrasound system with AI-powered tools, and SIGNA™ MAGNUS, a head-only MR scanner aimed at advancing neuroscience research. AI-driven CT technologies such as True Enhance DL and TrueFidelity DL deliver unparalleled imaging quality, improving diagnostic confidence.
Emphasizing Safety and Clinical Excellence
For diagnostic tools like Flyrcado™, GE HealthCare emphasizes safety precautions, including managing radiation exposure and ensuring proper settings for stress testing. These measures underline the company’s dedication to patient and provider safety while achieving clinical excellence.
Shaping the Future of Precision Healthcare
GE HealthCare’s extensive portfolio of innovations presented at RSNA 2024 exemplifies its commitment to advancing precision care. By integrating AI and digital technologies into medical devices and workflows, the company is driving efficiency, improving outcomes, and addressing the evolving challenges of healthcare delivery. To explore these groundbreaking technologies, visit GE HealthCare at Booth 7330 during RSNA 2024.
